
Additional Names: Gitogenin b-lycotetraoside
Percent Composition: C 57.13%, H 7.86%, O 35.01%
Literature References: Leaf saponin from Digitalis purpurea L., Scrophulariaceae: Kawasaki, Nishioka, Chem. Pharm. Bull. 12, 1311 (1964). Structure: Kawasaki et al., Tetrahedron 21, 299 (1965). A gitogenin tetraglycoside of which the sugar composition is 2 moles D-glucose, 1 mole D-galactose, and 1 mole D-xylose; differs from gitonin (the gitogenin tetraglycoside in D. purpurea seeds), in which the sugar composition is 2 galactose, 1 glucose, and 1 xylose: Tschesche, Wulff, Ber. 94, 2019 (1961).
CAS Name: (1E)-[2-[[6-(2-Chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloximeTrademarks: Fandango (Bayer CropSci.)
Percent Composition: C 54...
Literature References: Leaf-systemic broad-spectrum fungicide for use in cereal and food crops; member of methoxyimiodihydro-dioxazines. Prepn (stereochem. unspecified): U. Heinemann et al., DE 19602095; eidem, US 6103717 (1997, 2000 both to Bayer). Comprehensive description: S. Dutzmann et al., BCPC Conf. - Pests Dis. 2002, 365. Field trial in winter wheat seeds: I. Haeuser-Hahn et al., BCPC Int. Cong. - Crop Sci. Tech. 2003, 801. Series of articles on chemistry, biology, determn, and environmental fate: Pflanzenschutz-Nachr. Bayer (Engl. Ed.) 57, 299-449 (2004). Ecotoxicology: P. Breuer, ibid. 319.
CAS Name: N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide
Additional Names: 8-[4-(4-phenylbutoxy)benzamido]-2-(tetrazol-5-yl)-4H-1-benzopyran-4-one; 8-[p-(4-phen...
Literature References: Leukotriene antagonist. Prepn: M. Toda et al., EP 173516; eidem, US 4780469 (1986, 1988 both to Ono); H. Nakai et al., J. Med. Chem. 31, 84 (1988). Pharmacology: T. Obata et al., Adv. Prostaglandin Thromboxane Leukotriene Res. 15, 229 (1985); idem et al., ibid. 17, 540 (1987). Clinical evaluations in asthma: Y. Taniguchi et al., J. Allergy Clin. Immunol. 92, 507 (1993); H. Yamamoto et al. Am. J. Respir. Crit. Care Med. 150, 254 (1994).
CAS Name: 2-Methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-1-propanone
Additional Names: 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridineTrademarks: Ketas (Kyorin)
Percent Compositio...
Literature References: Leukotriene D4 antagonist. Prepn: T. Irikura et al., DE 2315801; eidem, US 3850941 (1973, 1974 both to Kyorin). Pharmacology and antiallergic activity: K. Nishino et al., Jpn. J. Pharmacol. 33, 267 (1983); H. Nagai et al., ibid. 1215. In vitro cerebral vasodilating activity: M. Ohashi et al., Arch. Int. Pharmacodyn. 280, 216 (1986); in vivo activity: W. M. Armstead et al., J. Pharmacol. Exp. Ther. 244, 138 (1988). Bronchodilating activity in animals: S. Mue et al., Arch. Int. Pharmacodyn. 283, 153 (1986). Antiplatelet activity in animals: M. Ohashi et al., ibid. 321; M. Ohashi et al., Gen. Pharmacol. 17, 385 (1986).
CAS Name: Tris(pentafluorophenyl)borane
Percent Composition: C 42.23%, B 2.11%, F 55.66%
Literature References: Lewis acid catalyst. Prepn and characterization: A. G. Massey, A. J. Park, J. Organomet. Chem. 2, 245 (1964); and NMR study of adducts: eidem, ibid. 5, 218 (1966). Catalytic role in olefin polymerization: X. Yang et al., J. Am. Chem. Soc. 116, 10015 (1994). Lewis acid properties: H. Jacobsen et al., Organometallics 18, 1724 (1999). Prepn and properties of B(C6F5)3 radical anion: R. J. Kwaan et al., ibid. 20, 3818 (2001). Review of chemistry and uses: W. E. Piers, T. Chivers, Chem. Soc. Rev. 26, 345-354 (1997).
CAS Name: Trifluoromethanesulfonic acid bismuth (3+) salt
Additional Names: Bismuth(III) tris(trifluoromethanesulfonate); Bi(OTf)3
Percent Composition: C 5.49%, Bi 31.85%, F 26.06%, O 21.94%...
Literature References: Lewis acid catalyst. Prepn: S. Singh et al., Indian J. Chem. 22A, 814 (1983); M. Labrouillère et al., Tetrahedron Lett. 40, 285 (1999). Catalysis of large scale acetylations of alcohols and diols: M. D. Carrigan et al., Synthesis 2001, 2091; of Biginelli Reaction: R. Varala et al., Synlett 2003, 67; of epoxide opening with aromatic amines: T. Ollevier, G. Lavie-Compin, Tetrahedron Lett. 45, 49 (2004). Review as catalyst for acylations and sulfonylations: C. Le Roux, J. Dubac, Synlett 2002, 181-200; brief review of catalytic use in a variety of organic reactions: S. Antoniotti, ibid. 2003, 1566-1567.
CAS Name: threo-Pentulose
Percent Composition: C 40.00%, H 6.71%, O 53.29%
Literature References: L-Form has been found in the urine of humans with pentosuria. Prepn of DL-form: Gascoigne, Chem. Ind. (London) 1959, 402; of D-form: Mendicino, J. Am. Chem. Soc. 82, 4975 (1960); of L-form: Wolfrom, Bennett, J. Org. Chem. 30, 458 (1965). Isoln of DL-form from the acid hydrolysate of bagasse hemicellulose: Banerjee et al., Sci. Cult. 27, 498 (1961), C.A. 56, 11682d (1962). Enzymic prepn of L-form: Hough, Jones, Chem. Ind. (London) 1952, 907; eidem, J. Chem. Soc. 1952, 4047. Formation of L-form in normal humans and guinea pigs, and its utilization by guinea-pig liver prepns: Touster et al., J. Am. Chem. Soc. 76, 5005 (1954). Reviews: The Carbohydrates, W. Pigman, Ed. (Academic Press, New York, 1957) pp 80, 86-87, 759, 795; Methods in Carbohydrate Chemistry vol. 1, R. L. Whistler, M. L. Wolfrom, Eds. (Academic Press, New York, 1962) pp 94-101.
Trademarks: Photofrin (Axcan)
Literature References: Light sensitive polyporphyrin oligomer linked via ethers and esters; purification product of hematoporphyrin derivative. Forms aggregates with combined mol wt ~10000. Prepn: T. J. Dougherty et al., "Photoradiation Therapy - Clinical and Drug Advances" in Porphyrin Photosensitization, D. Kessel, T. J. Dougherty, Eds. (Plenum Press, New York, 1983) pp 3-13; T. J. Dougherty et al., US 4649151 (1987 to Health Res.). Structural studies: idem, Photochem. Photobiol. 46, 569 (1987); R. K. Pandey et al., Biomed. Environ. Mass Spectrom. 19, 405 (1990). Photobleaching: J. Moan, D. Kessel, J. Photochem. Photobiol. B 1, 429 (1988); J. D. Spikes, Photochem. Photobiol. 55, 797 (1992). Pharmacokinetics in mice: D. A. Bellnier et al., ibid. 50, 221 (1989). Clinical evaluation in treatment of esophageal cancer: T. Okunaka et al., Surg. Endosc. 4, 150 (1990). Imaging study for premalignant lesions: C. Liebow et al., Proc. Natl. Acad. Sci. USA 90, 1897 (1993). Clinical use as imaging agent for lung cancer: S. Lam et al., Chest 97, 333 (1990).
CAS Name: (7S,8R,9R)-9-(1,3-Benzodioxol-5-yl)-6,7,8,9-tetrahydro-7,8-dimethylnaphtho[1,2-d]-1,3-dioxole
Additional Names: 5,6-methylenedioxy-2,3-dimethyl-4-(3',4'-methylenedioxyphenyl)-1,2,3,4-...
Literature References: Lignan isolated from otoba butter, the fat expressed from the fruit of Myristica otoba Humb. Bonpl., Myristicaceae. Isoln: W. F. Baughman et al., J. Am. Chem. Soc. 43, 199 (1921). Structure: T. Gilchrist et al., J. Chem. Soc. 1962, 1780; N. S. Bhacca, R. Stevenson, J. Org. Chem. 28, 1638 (1963). Absolute configuration: W. Klyne et al., J. Chem. Soc. C 1966, 893. Synthesis of (±)-form: I. Maclean, R. Stevenson, ibid. 1717; T. B. H. McMurry, H. K. Kennedy-Skipton, Tetrahedron Lett. 1966, 975.
CAS Name: Poly[imino(1-oxo-1,6-hexanediyl)]
Additional Names: poly(iminocarbonylpentamethylene)
Trademarks: Caprolan (AlliedSignal); Enkalon (Am. Enka); Grilon (Fibron); Kapron (Klin); Mirlo...
Literature References: Linear polymer obtained by polymerization of e-caprolactam, q.v.: Schlack, US 2241321 (1941 to I. G. Farbenind.). The importance of this fiber increased with the discovery that caprolactam can be produced by the nitrosation of cyclohexanecarboxylic acid: Muench et al., US 3022291 and US 3108096 (1962, 1963, both to Snia Viscosa). Review: R. W. Moncrieff, Man-Made Fibres (John Wiley Sons, New York, 1963) pp 335-355; H. K. Reimschuessel, J. Polym. Sci. Macromol. Rev. 12, 65-139 (1977).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
